Cardiovascular Effects of Autologous Bone Marrow–Derived Mesenchymal Stromal Cell Therapy With Early Tacrolimus Withdrawal in Renal Transplant Recipients: An Analysis of the Randomized TRITON Study

BACKGROUND: After renal transplantation, there is a need of immunosuppressive regimens that effectively prevent allograft rejection while minimizing cardiovascular complications. This substudy of the TRITON trial evaluated the cardiovascular effects of autologous bone marrow–derived mesenchymal stro...

Descripción completa

Detalles Bibliográficos
Autores principales: Meucci, Maria Chiara, Reinders, Marlies E. J., Groeneweg, Koen E., Bezstarosti, Suzanne, Ajmone Marsan, Nina, Bax, Jeroen J., De Fijter, Johan W., Delgado, Victoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075245/
https://www.ncbi.nlm.nih.gov/pubmed/34913362
http://dx.doi.org/10.1161/JAHA.121.023300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075245/
https://www.ncbi.nlm.nih.gov/pubmed/34913362
http://dx.doi.org/10.1161/JAHA.121.023300

Ejemplares similares